In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Indian cricket team's opening batsman Shikhar Dhawan is out of the team these days. Even away fro
Horrific: More than 36 thousand lives taken away by Corona in 10 days, 150 people lost every hour
The second wave of the Corona epidemic has caused panic all over the country. Every day there is
Prime Minister Modi addressed the webinar organized on 'Urban Planning, Development and Sanitatio
Today is a big day for Delhi Chief Minister Arvind Kejriwal, who is facing trial as the main accu
Imran Khan, the head of Pakistan Tehreek-e-Insaf, seems to be caught in another controversy. This
The trailer of the South movie Pushpa 2 is to be launched today (17 November) at Gandhi Maidan in
US Vice President Kamala Harris's husband Douglas Emhoff has been rescued by security after recei
The southern districts of Tamil Nadu are facing a flood-like situation these days. It has been ra
There was an explosion in a vehicle on Wednesday in Larkipora of Anantnag in South Kashmir. Eight
KGF 2 halted the pace of 'Beast'? Still earned so many crores in 5 days
Vijay starrer film 'Beast' has reached close to 200 crores in just 5 days. The Hindi version of t
